HMG-CoA reductase is regulated by salinity at the level of transcription in Haloferax volcanii

被引:29
|
作者
Bidle, Kelly A.
Hanson, Thomas E.
Howell, Koko
Nannen, Jennifer
机构
[1] Rider Univ, Dept Biol, Lawrenceville, NJ 08648 USA
[2] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA
[3] Univ Delaware, Grad Coll Marine Studies, Newark, DE 19711 USA
基金
美国国家科学基金会;
关键词
haloarchaea; HMG-CoA reductase; salt regulation; lipids; carotenoids;
D O I
10.1007/s00792-006-0008-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The moderately halophilic archaeon Haloferax volcanii was surveyed for protein profile changes correlated with growth at high and low salinity. A single polypeptide with an approximate mass of 46 kDa was conspicuously more abundant during growth at high salinity. This protein was identified as HMG-CoA reductase (HMGR), encoded by the hmgR gene. HMGR is a key enzyme in the mevalonate pathway of isoprenoid biosynthesis, the sole route in haloarchaea for lipid and carotenoid production. Enzymatic assays confirmed that HMGR activity is more abundant in cells grown at high salinity. Low salt cultures of H. volcanii contained lower amounts of hmg R transcript compared to cells grown in high salt suggesting that the observed regulation occurs at the level of transcription. Paradoxically, both lipid and carotenold content decreased in H. volcanii grown at high salinity despite the increased levels of HMGR specific activity. To our knowledge, this is the first report demonstrating that the expression of HMGR is regulated in response to non-optimal salinity in a halophilic archaeon.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 50 条
  • [41] Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors
    Kiener, PA
    Davis, PM
    Murray, JL
    Youssef, S
    Rankin, BM
    Kowala, MK
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (01) : 105 - 118
  • [42] DISPOSITION OF FLUVASTATIN, AN INHIBITOR OF HMG-COA REDUCTASE, IN MOUSE, RAT, DOG, AND MONKEY
    TSE, FLS
    SMITH, HT
    BALLARD, FH
    NICOLETTI, J
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1990, 11 (06) : 519 - 531
  • [43] Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients
    Martin, Jill E.
    Cavanaugh, Teresa M.
    Trumbull, Leslie
    Bass, Maryetta
    Weber, Fredrick, Jr.
    Aranda-Michel, Jaime
    Hanaway, Michael
    Rudich, Steven
    CLINICAL TRANSPLANTATION, 2008, 22 (01) : 113 - 119
  • [44] Farnesol as a regulator of HMG-CoA reductase degradation: Characterization and role of farnesyl pyrophosphatase
    Meigs, TE
    Simoni, RD
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 345 (01) : 1 - 9
  • [45] HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins
    Dansette, PM
    Jaoen, M
    Pons, C
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2000, 52 (02) : 145 - 148
  • [46] Supernatant protein factor stimulates HMG-CoA reductase in cell culture and in vitro
    Mokashi, V
    Singh, DK
    Porter, TD
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 433 (02) : 474 - 480
  • [47] PROGESTERONE STIMULATION OF HMG-COA REDUCTASE-ACTIVITY IN CULTURED-CELLS
    SEXTON, RC
    GUPTA, AK
    PANINI, SR
    RUDNEY, H
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1255 (03): : 320 - 332
  • [48] Synthesis and antihyperlipidemic efficiency of berberine-based HMG-CoA reductase inhibitor
    Ye, Xiaoli
    He, Kai
    Zhu, Xiaokang
    Zhang, Baoshun
    Chen, Xin
    Yi, Jun
    Li, Xuegang
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (07) : 1353 - 1362
  • [49] The HMG-CoA reductase inhibitor cerivastatin enhances the nitric oxide bioavailability of the endothelium
    Berkels, R
    Nouri, SK
    Taubert, D
    Bartels, H
    Roesen, P
    Roesen, R
    Klaus, WF
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 (03) : 356 - 363
  • [50] Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver
    Keller, RK
    Zhao, ZH
    Chambers, C
    Ness, GC
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 328 (02) : 324 - 330